Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Operating Expenses of $12.3 million for Q1 2026, down 18.53% sequentially from $15.0 million in Q4 2025, and up 17.65% YoY from $10.4 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Operating Expenses for 17 years, with the latest figure at $12.3 million in Q1 2026.
- Quarterly Operating Expenses rose 17.65% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.2 million (up 10.82% YoY) and the FY2025 annual result came in at $47.3 million, up 6.8% from the prior year.
- Operating Expenses declined to $12.3 million in Q1 2026 per CPIX's latest filing, from $15.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $15.5 million in Q4 2023 and troughed at $10.3 million in Q3 2025.
- A 5-year average of $11.8 million and a median of $11.6 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 36.23% in 2023, then retreated 20.95% in 2024.
- Over 5 years, Operating Expenses stood at $11.4 million in 2022, then surged by 36.23% to $15.5 million in 2023, then decreased by 20.95% to $12.3 million in 2024, then climbed by 22.58% to $15.0 million in 2025, then slipped by 18.53% to $12.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $12.3 million, $15.0 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.16 Mn | 110.30 Mn | - | 3.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.33 Mn |
| Mar 31, 2026 | 12.26 Mn |
| Dec 31, 2025 | 15.05 Mn |
| Sep 30, 2025 | 10.26 Mn |
| Jun 30, 2025 | 11.58 Mn |
| Mar 31, 2025 | 10.42 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 10.78 Mn |
| Jun 30, 2024 | 10.88 Mn |
| Mar 31, 2024 | 10.37 Mn |
| Dec 31, 2023 | 15.53 Mn |
| Sep 30, 2023 | 11.95 Mn |
| Jun 30, 2023 | 10.87 Mn |
| Mar 31, 2023 | 10.76 Mn |
| Dec 31, 2022 | 11.40 Mn |
| Sep 30, 2022 | 11.70 Mn |
| Jun 30, 2022 | 12.15 Mn |
| Mar 31, 2022 | 12.47 Mn |
| Dec 31, 2021 | 12.67 Mn |
| Sep 30, 2021 | 9.64 Mn |